​
A Bit About Me
My name is Skip
I've worked at several Pharma companies over the past 30 years and have gained a lot of experience that I can share with you.
The areas of Real World Evidence (RWE) and Health Economics & Outcomes Research (HEOR) are tricky to perform given all the technical issues involved. Not only can I help with those, but, in addition, I've developed expertise in quantifying their value to help align internal partners around external stakeholder needs. And, did I mention Implementation Science? It's an interesting area that's not to be missed.
You might be wondering how I got the nickname, Skip. I grew up in a fishing town outside of Boston (Gloucester to be exact) where the name "Skipper", i.e. captain of a boat, or shortened "Skip" were common nicknames. Mine was given to me practically at birth and has stuck.
After getting my doctorate (ScD) in biostatistics at Harvard, I moved to Switzerland to begin my career in the Pharma industry and I've (mostly) been here since. I speak German and am a Swiss citizen. I live outside Basel with my wife and our two cats.
Recent Work Experience
2021 - 2023
2016 - 2021
Global Head of Integrated Evidence Strategy and Innovation: Developed a framework for putting a value on Evidence, both monetary and patient-centric. Worked with program teams to use value framework to drive the business. Published on both Implementation Science and the Value of Evidence (coming soon) and how they can drive internal alignment and evidence-driven decision making and, thus, bring overall value to the company.
Global Head of RWE Strategy and Innovation: Built a global RWE community. Created and delivered global initiatives such as "Secondary Data First" and "Go Early with Evidence" to drive the strategic use of RWE. Extensive training programs and workshops were created and delivered across the globe to strengthen the awareness, understanding, and practice of RWE.
2005 - 2015
Global Head HEOR Excellence and other HEOR Roles: Explored and brought cutting-edge methods to the company including network meta-analysis, patient-level simulation models, machine learning, high value subgroups, and social media listening. Created and led teams across the globe for database analyses and economic models.
I'm on LinkedIn
